KOSPI · Healthcare · ₩181B
₩959+1.48%
What's this stock's score right now?
See its score for free — revenue and money flow, graded on one standard.
Quarterly Financials
6/'26
3/'26 vs prev quarter
Short Volume 5.5% · as of 26.10.27
Among 97 제약 peers
Quarterly Revenue Growth
“이번 분기, 매출보다 실제로 남기는 힘이 더 중요해졌어요.”
In the company's words · 2026 2분기 filing